BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9148649)

  • 1. Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant pleural effusion.
    Lan RS; Lo SK; Chuang ML; Yang CT; Tsao TC; Lee CH
    Ann Intern Med; 1997 May; 126(10):768-74. PubMed ID: 9148649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship of Pleural Manometry With Postthoracentesis Chest Radiographic Findings in Malignant Pleural Effusion.
    Chopra A; Judson MA; Doelken P; Maldonado F; Rahman NM; Huggins JT
    Chest; 2020 Feb; 157(2):421-426. PubMed ID: 31472154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases.
    Martínez-Moragón E; Aparicio J; Sanchis J; Menéndez R; Cruz Rogado M; Sanchis F
    Respiration; 1998; 65(2):108-13. PubMed ID: 9580921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid pleurodesis for malignant pleural effusions.
    Spiegler PA; Hurewitz AN; Groth ML
    Chest; 2003 Jun; 123(6):1895-8. PubMed ID: 12796165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH.
    Aelony Y; King RR; Boutin C
    Chest; 1998 Apr; 113(4):1007-12. PubMed ID: 9554639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions.
    Ong KC; Indumathi V; Raghuram J; Ong YY
    Respirology; 2000 Jun; 5(2):99-103. PubMed ID: 10894097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Massive Pleural Effusion: Pleurodesis by Bleomycin.
    Hasan R; Khan OS; Aftabuddin M; Razzaque AM; Chowdhury GA
    Mymensingh Med J; 2016 Apr; 25(2):374-8. PubMed ID: 27277376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of recurrent malignant pleural effusion with chemical pleurodesis.
    Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C
    Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-EDIT: A Randomized Feasibility Trial of Elastance-Directed Intrapleural Catheter or Talc Pleurodesis in Malignant Pleural Effusion.
    Martin GA; Tsim S; Kidd AC; Foster JE; McLoone P; Chalmers A; Blyth KG
    Chest; 2019 Dec; 156(6):1204-1213. PubMed ID: 31374208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage.
    Salamonsen MR; Lo AKC; Ng ACT; Bashirzadeh F; Wang WYS; Fielding DIK
    Chest; 2014 Nov; 146(5):1286-1293. PubMed ID: 25010364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.
    Diacon AH; Wyser C; Bolliger CT; Tamm M; Pless M; Perruchoud AP; Solèr M
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1445-9. PubMed ID: 11029359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion.
    Masoud HH; El-Zorkany MM; Ahmed AA; Assal HH
    Tuberc Respir Dis (Seoul); 2021 Jan; 84(1):67-73. PubMed ID: 33161689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of malignant pleural effusions.
    Sahn SA
    Monaldi Arch Chest Dis; 2001 Oct; 56(5):394-9. PubMed ID: 11887496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.
    Burrows CM; Mathews WC; Colt HG
    Chest; 2000 Jan; 117(1):73-8. PubMed ID: 10631202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural fluid glucose: A predictor of unsuccessful pleurodesis in a preselected cohort of patients with malignant pleural effusion.
    Pantazopoulos I; Xanthos T; Vlachos I; Kakoulas Z; Stroumpoulis K; Chalkias A; Tsoukalas G; Koutsoukou A
    J BUON; 2014; 19(4):1018-23. PubMed ID: 25536610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of iodopovidone versus bleomycin in chemical pleurodesis.
    Bagheri R; Noori M; Rajayi M; Attaran D; Mohammad Hashem Asna Ashari A; Mohammadzadeh Lari S; Basiri R; Rezaeetalab F; Afghani R; Salehi M
    Asian Cardiovasc Thorac Ann; 2018 Jun; 26(5):382-386. PubMed ID: 29792037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
    Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
    Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage.
    Patz EF; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Gilkeson RC; Herndon J
    Chest; 1998 May; 113(5):1305-11. PubMed ID: 9596311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions.
    Zimmer PW; Hill M; Casey K; Harvey E; Low DE
    Chest; 1997 Aug; 112(2):430-4. PubMed ID: 9266880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.